Home / Centerstage / 2015 / March / Week 1 /
American pharmaceutical company AbbVie Inc acquires Pharmacyclics Inc, a leukemia drugmaker, for $21 billion. This strategic acquisition expands AbbVie's oncology portfolio and strengthens its position in the highly competitive pharmaceutical industry, aiming to provide innovative treatments for patients with hematologic malignancies.
Wednesday, 4 March, 2015